Cart
sales@molnova.com
TR-107
CAS No. 2485052-87-5
TR-107( —— )
Catalog No. M37552 CAS No. 2485052-87-5
TR-107 (Anticancer agent 230) is a selective and potent activator of the mitochondrial protease ClpP that inhibits tumor growth in the MDA-MB-231 xenograft model.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 38 | In Stock |
|
| 10MG | 61 | In Stock |
|
| 25MG | 123 | In Stock |
|
| 50MG | 193 | In Stock |
|
| 100MG | 305 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 732 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTR-107
-
NoteResearch use only, not for human use.
-
Brief DescriptionTR-107 (Anticancer agent 230) is a selective and potent activator of the mitochondrial protease ClpP that inhibits tumor growth in the MDA-MB-231 xenograft model.
-
DescriptionTR-107 (Anticancer agent 230) is a selective and potent activator of the mitochondrial protease ClpP that inhibits tumor growth in the MDA-MB-231 xenograft model.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayProteasome/Ubiquitin
-
TargetSerine Protease
-
RecptorProtease
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2485052-87-5
-
Formula Weight390.87
-
Molecular FormulaC22H19ClN4O
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESN#CC1=CC=CC(=C1)CN2CC=3C(=O)N(C=NC3CC2)CC4=CC=C(Cl)C=C4
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
4-Aminobenzamidine d...
4-Aminobenzamidine dihydrochloride (p-Aminobenzamidine dihydrochloride) is a strong trypsin inhibitor and a relatively weak inhibitor of urokinase type plasminogen activator (uPA) (K i =82 μM).
-
APD597
APD597 is a GPR119 agonist, used in the treatment of type 2 diabetes.
-
Demethylwedelolacton...
Demethylwedelolactone is a natural product isolated from Eclipta alba,?has trypsin inhibitory effect an IC50 of 3.0 μM. it exerts anti-invasive growth effect on breast cancer cells.demethylwedelolactone (DWEL) inhibited the anchorage-independent growth and also suppressed cell motility and cell invasion of MDA-MB-231 cells.
